Enhanced Vascularisation and Growth of Stem Cell Derived Human Myocardial Grafts

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

300 000 Australians currently have heart failure with 400 new cases weekly. New therapies are urgently needed. We can now create heart muscle grafts that can be transplanted after ñheart attackî but graft survival in this hostile environment is low. This project will investigate use of different combinations of human cell types that will cooperate together to improve survival/function of heart muscle grafts, advancing this promising strategy towards being a viable new treatment for heart failure

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2015

Funding Scheme: Early Career Fellowships

Funding Amount: $382,346.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cardiac dysfunction | cardiomyocytes | cardiovascular disease | heart failure | myocardial infarction | stem cell biology | stem cell therapy